Testing effectiveness (Phase 2)Active Not RecruitingNCT03794349
What this trial is testing
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRefractory Neuroblastoma
Children's Oncology Group 94